drugset / Trial / NCT02538367
Phase 1/2a Trial of YH12852 in Healthy Subjects and Patients With Functional Constipation
RandomizedParallel-groupDouble-blind
Summary
A randomized, double-blind/open-label, placebo/active-controlled, single/multiple dose, parallel, phase 1/2a trial to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of YH12852 in healthy subjects and patients with functional constipation
Timeline
- Start
- 2015-08
- Primary completion
- 2016-09
- Completion
- 2016-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Prucalopride | Small molecule | 2 mg | — |
| Subject | YH12852 | Unknown | 0.05 mg | — |
| Subject | YH12852 | Unknown | 0.1 mg | — |
| Subject | YH12852 | Unknown | 0.3 mg | — |
| Subject | YH12852 | Unknown | 0.5 mg | — |
| Subject | YH12852 | Unknown | 1 mg | — |
| Subject | YH12852 | Unknown | 2 mg | — |
| Subject | YH12852 | Unknown | 3 mg | — |
| Subject | YH12852 | Unknown | 4 mg | — |
| Subject | YH12852 | Unknown | 8 mg | — |